Abstract
Activation of complement by Entamoeba histolytica may be initiated by the extracellular 56-kD neutral cysteine proteinase which cleaves the alpha chain of C3. To determine the relationship between the fluid-phase activation of complement and our observation that only strains isolated from patients with invasive disease are resistant to complement-mediated lysis, we investigated the fate of C3 with recent amebic isolates. When 125I-C3 was incubated with trophozoites in serum, C3 in the fluid phase was cleaved to C3b or C3bi, but the alpha chain of the C3 molecules on the cell surface appeared intact. Since the lysis of nonpathogenic strains takes place in the absence of bound C3b, we demonstrated that this reaction occurs by reactive lysis initiated in the fluid phase: (a) the killing of nonpathogenic strains was enhanced when alternative pathway activation was accelerated by the addition of cobra venom factor; (b) non-pathogenic strains were lysed by purified terminal components; and (c) sera incubated with pathogenic E. histolytica produced passive lysis of chicken erythrocytes. These results demonstrate for the first time that complement-sensitive E. histolytica are lysed by activation of the terminal complement components in the fluid phase where the 56-kD neutral cysteine proteinase cleaves C3, and not by the surface deposition of activated C3.
Full text
PDF![1815](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3769/329813/83ff71ad199c/jcinvest00486-0061.png)
![1816](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3769/329813/8337d9bb7089/jcinvest00486-0062.png)
![1817](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3769/329813/b6c616dca58f/jcinvest00486-0063.png)
![1818](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3769/329813/5699e1fcbf47/jcinvest00486-0064.png)
![1819](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3769/329813/10c83543d2d1/jcinvest00486-0065.png)
![1820](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3769/329813/645e9b6fa490/jcinvest00486-0066.png)
![1821](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3769/329813/b5e878e26417/jcinvest00486-0067.png)
![1822](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3769/329813/9d84ea3732ff/jcinvest00486-0068.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barrett A. J., Kembhavi A. A., Brown M. A., Kirschke H., Knight C. G., Tamai M., Hanada K. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J. 1982 Jan 1;201(1):189–198. doi: 10.1042/bj2010189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Calderon J., Schreiber R. D. Activation of the alternative and classical complement pathways by Entamoeba histolytica. Infect Immun. 1985 Nov;50(2):560–565. doi: 10.1128/iai.50.2.560-565.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cooper N. R., Müller-Eberhard H. J. The reaction mechanism of human C5 in immune hemolysis. J Exp Med. 1970 Oct 1;132(4):775–793. doi: 10.1084/jem.132.4.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis A. E., 3rd, Harrison R. A., Lachmann P. J. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g. J Immunol. 1984 Apr;132(4):1960–1966. [PubMed] [Google Scholar]
- Diamond L. S. A new liquid medium for xenic cultivation of Entamoeba histolytica and other lumen-dwelling protozoa. J Parasitol. 1982 Oct;68(5):958–959. [PubMed] [Google Scholar]
- Diamond L. S., Harlow D. R., Cunnick C. C. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 1978;72(4):431–432. doi: 10.1016/0035-9203(78)90144-x. [DOI] [PubMed] [Google Scholar]
- Diamond L. S., Phillips B. P., Bartgis I. L. A comparison of the virulence of nine strains of axenically cultivated E. histolytica in hamster liver. Arch Invest Med (Mex) 1974;5(Suppl 2):423–426. [PubMed] [Google Scholar]
- Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
- Fuhrman S. A., Joiner K. A. Complement evasion by protozoa. Exp Parasitol. 1989 May;68(4):474–481. doi: 10.1016/0014-4894(89)90133-1. [DOI] [PubMed] [Google Scholar]
- Fuhrman S. A., Joiner K. A. Toxoplasma gondii: mechanism of resistance to complement-mediated killing. J Immunol. 1989 Feb 1;142(3):940–947. [PubMed] [Google Scholar]
- Garfinkel L. I., Giladi M., Huber M., Gitler C., Mirelman D., Revel M., Rozenblatt S. DNA probes specific for Entamoeba histolytica possessing pathogenic and nonpathogenic zymodemes. Infect Immun. 1989 Mar;57(3):926–931. doi: 10.1128/iai.57.3.926-931.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gillin F. D., Sher A. Activation of the alternative complement pathway by Trichomonas vaginalis. Infect Immun. 1981 Oct;34(1):268–273. doi: 10.1128/iai.34.1.268-273.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gitler C., Calef E., Rosenberg I. Cytopathogenicity of Entamoeba histolytica. Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):73–85. doi: 10.1098/rstb.1984.0110. [DOI] [PubMed] [Google Scholar]
- Goldman J. N., Austen K. F. Reaction mechanisms of nascent C567 (reactive lysis). II. Killing of a rough form of Escherichia coli by C567, C8, and C9. J Infect Dis. 1974 Apr;129(4):444–450. doi: 10.1093/infdis/129.4.444. [DOI] [PubMed] [Google Scholar]
- Goldman J. N., Ruddy S., Austen K. F. Reaction mechanisms of nascent C567 (reactive lysis). I. Reaction characteristics for production of EC567 and lysis by C8 and C9. J Immunol. 1972 Aug;109(2):353–359. [PubMed] [Google Scholar]
- Götze O., Müller-Eberhard H. J. Lysis of erythrocytes by complement in the absence of antibody. J Exp Med. 1970 Nov;132(5):898–915. doi: 10.1084/jem.132.5.898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harriman G. R., Podack E. R., Braude A. I., Corbeil L. C., Esser A. F., Curd J. G. Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death. J Exp Med. 1982 Oct 1;156(4):1235–1249. doi: 10.1084/jem.156.4.1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holguin M. H., Fredrick L. R., Bernshaw N. J., Wilcox L. A., Parker C. J. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest. 1989 Jul;84(1):7–17. doi: 10.1172/JCI114172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hostetter M. K., Krueger R. A., Schmeling D. J. The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement. J Infect Dis. 1984 Nov;150(5):653–661. doi: 10.1093/infdis/150.5.653. [DOI] [PubMed] [Google Scholar]
- Janatova J., Lorenz P. E., Schechter A. N., Prahl J. W., Tack B. F. Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation. Biochemistry. 1980 Sep 16;19(19):4471–4478. [PubMed] [Google Scholar]
- Joiner K. A., Warren K. A., Brown E. J., Swanson J., Frank M. M. Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae. J Immunol. 1983 Sep;131(3):1443–1451. [PubMed] [Google Scholar]
- Keene W. E., Petitt M. G., Allen S., McKerrow J. H. The major neutral proteinase of Entamoeba histolytica. J Exp Med. 1986 Mar 1;163(3):536–549. doi: 10.1084/jem.163.3.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim S. H., Carney D. F., Hammer C. H., Shin M. L. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process. J Immunol. 1987 Mar 1;138(5):1530–1536. [PubMed] [Google Scholar]
- Kitamura F., Shimada K., Suzuki T., Nishioka K. A simplified method for the preparation of EAC14 intermediate cells using human serum treated with methylprednisolone. J Immunol Methods. 1985 Dec 27;85(2):363–370. doi: 10.1016/0022-1759(85)90145-0. [DOI] [PubMed] [Google Scholar]
- Kobiler D., Mirelman D. Lectin activity in Entamoeba histolytica trophozoites. Infect Immun. 1980 Jul;29(1):221–225. doi: 10.1128/iai.29.1.221-225.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Law S. K., Lichtenberg N. A., Levine R. P. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces. J Immunol. 1979 Sep;123(3):1388–1394. [PubMed] [Google Scholar]
- Lundwall A., Eggertsen G. Isolation of human complement factors C3, C5 and H. J Immunol Methods. 1985 Jul 16;81(1):147–160. doi: 10.1016/0022-1759(85)90131-0. [DOI] [PubMed] [Google Scholar]
- Martin D. E., Chiu F. J., Gigli I., Müller-Eberhard H. J. Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition. J Clin Invest. 1987 Jul;80(1):226–233. doi: 10.1172/JCI113052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morgan B. P., Dankert J. R., Esser A. F. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. J Immunol. 1987 Jan 1;138(1):246–253. [PubMed] [Google Scholar]
- Petri W. A., Jr, Smith R. D., Schlesinger P. H., Murphy C. F., Ravdin J. I. Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica. J Clin Invest. 1987 Nov;80(5):1238–1244. doi: 10.1172/JCI113198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Podack E. R., Kolb W. P., Müller-Eberhard H. J. The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum. J Immunol. 1978 Jun;120(6):1841–1848. [PubMed] [Google Scholar]
- Polley M. J., Müller-Eberhard H. J. Enharncement of the hemolytic activity of the second component of human complement by oxidation. J Exp Med. 1967 Dec 1;126(6):1013–1025. doi: 10.1084/jem.126.6.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Puentes S. M., Sacks D. L., da Silva R. P., Joiner K. A. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Exp Med. 1988 Mar 1;167(3):887–902. doi: 10.1084/jem.167.3.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reed S. L., Curd J. G., Gigli I., Gillin F. D., Braude A. I. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica. J Immunol. 1986 Mar 15;136(6):2265–2270. [PubMed] [Google Scholar]
- Reed S. L., Gault M., Gillin F. D., Gigli I., Braude A. I., Curd J. G., Sargeaunt P. G. Interaction of pathogenic and nonpathogenic Entamoeba histolytica with human complement. Arch Invest Med (Mex) 1987 Apr-Jun;18(2):141–149. [PubMed] [Google Scholar]
- Reed S. L., Keene W. E., McKerrow J. H., Gigli I. Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica. J Immunol. 1989 Jul 1;143(1):189–195. [PubMed] [Google Scholar]
- Reed S. L., Keene W. E., McKerrow J. H. Thiol proteinase expression and pathogenicity of Entamoeba histolytica. J Clin Microbiol. 1989 Dec;27(12):2772–2777. doi: 10.1128/jcm.27.12.2772-2777.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reed S. L., Sargeaunt P. G., Braude A. I. Resistance to lysis by human serum of pathogenic Entamoeba histolytica. Trans R Soc Trop Med Hyg. 1983;77(2):248–253. doi: 10.1016/0035-9203(83)90083-4. [DOI] [PubMed] [Google Scholar]
- Robinson G. L. The laboratory diagnosis of human parasitic amoebae. Trans R Soc Trop Med Hyg. 1968;62(2):285–294. doi: 10.1016/0035-9203(68)90170-3. [DOI] [PubMed] [Google Scholar]
- Sargeaunt P. G., Williams J. E. Electrophoretic isoenzyme patterns of Entamoeba histolytica and Entamoeba coli. Trans R Soc Trop Med Hyg. 1978;72(2):164–166. doi: 10.1016/0035-9203(78)90053-6. [DOI] [PubMed] [Google Scholar]
- Sim E., Wood A. B., Hsiung L. M., Sim R. B. Pattern of degradation of human complement fragment, C3b. FEBS Lett. 1981 Sep 14;132(1):55–60. doi: 10.1016/0014-5793(81)80426-7. [DOI] [PubMed] [Google Scholar]
- Sim R. B., Sim E. Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin. Biochem J. 1981 Jan 1;193(1):129–141. doi: 10.1042/bj1930129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strachan W. D., Chiodini P. L., Spice W. M., Moody A. H., Ackers J. P. Immunological differentiation of pathogenic and non-pathogenic isolates of Entamoeba histolytica. Lancet. 1988 Mar 12;1(8585):561–563. doi: 10.1016/s0140-6736(88)91355-4. [DOI] [PubMed] [Google Scholar]
- Tack B. F., Harrison R. A., Janatova J., Thomas M. L., Prahl J. W. Evidence for presence of an internal thiolester bond in third component of human complement. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5764–5768. doi: 10.1073/pnas.77.10.5764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tannich E., Horstmann R. D., Knobloch J., Arnold H. H. Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5118–5122. doi: 10.1073/pnas.86.13.5118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson R. A., Lachmann P. J. Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J Exp Med. 1970 Apr 1;131(4):629–641. doi: 10.1084/jem.131.4.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson R. A., Rowe D. S. Reactive haemolysis--a distinctive form of red cell lysis. Immunology. 1968 May;14(5):745–762. [PMC free article] [PubMed] [Google Scholar]
- Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vogel C. W., Müller-Eberhard H. J. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. J Biol Chem. 1982 Jul 25;257(14):8292–8299. [PubMed] [Google Scholar]
- Zalman L. S., Wood L. M., Müller-Eberhard H. J. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6975–6979. doi: 10.1073/pnas.83.18.6975. [DOI] [PMC free article] [PubMed] [Google Scholar]